fluoxetine has been researched along with raclopride in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Buckley, DB; Funk, RS; Hensley, T; Kazmi, F; Loewen, GJ; Parkinson, A; Pope, C | 1 |
Tsuchiya, K | 1 |
Cistarelli, L; Gobert, A; Melon, C; Millan, MJ; Rivet, JM | 1 |
Aalto, S; Hietala, J; Hirvonen, J; Ilonen, T; Kajander, J; Någren, K; Penttilä, J; Syvälahti, E | 1 |
Biegon, A; Ding, YS; Fowler, J; Lin, KS; Logan, J; Pareto, D | 1 |
Aalto, S; Hietala, J; Hirvonen, J; Kajander, J; Karlsson, H; Markkula, J; Någren, K; Rasi-Hakala, H; Salminen, JK | 1 |
2 trial(s) available for fluoxetine and raclopride
Article | Year |
---|---|
Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride.
Topics: Adult; Brain Chemistry; Brain Mapping; Fluoxetine; Humans; Male; Neostriatum; Positron-Emission Tomography; Putamen; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Selective Serotonin Reuptake Inhibitors; Thalamus | 2004 |
Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C]raclopride PET.
Topics: Adult; Antidepressive Agents, Second-Generation; Carbon Radioisotopes; Corpus Striatum; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Positron-Emission Tomography; Psychotherapy; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Thalamus | 2011 |
5 other study(ies) available for fluoxetine and raclopride
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).
Topics: Adrenergic beta-Antagonists; Amines; Ammonium Chloride; Antidepressive Agents, Tricyclic; Atorvastatin; Cell Line, Transformed; Diuretics; Hepatocytes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipramine; Lysosomes; Monensin; Nigericin; Propranolol; Pyrroles | 2013 |
[Effects of methamphetamine on responsiveness to conditioned fear stress].
Topics: Animals; Benzamides; Benzazepines; Brain Chemistry; Central Nervous System Stimulants; Conditioning, Psychological; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Fear; Fluoxetine; Homovanillic Acid; Male; Methamphetamine; Nalidixic Acid; Naphthyridines; Raclopride; Rats; Rats, Wistar; Salicylamides; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 1999 |
Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brain Chemistry; Buspirone; Chromatography, High Pressure Liquid; Dopamine; Dopamine Antagonists; Drug Interactions; Fluoxetine; Frontal Lobe; Locomotion; Male; Microdialysis; Neural Inhibition; Norepinephrine; Oxazoles; Piperazines; Pyridines; Raclopride; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1999 |
Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.
Topics: Animals; Brain; Carbon Radioisotopes; Fluorine Radioisotopes; Fluoxetine; Ligands; Morpholines; Papio; Positron-Emission Tomography; Raclopride; Reboxetine | 2005 |